From: Jessica Oldham [joldham@bio.org]
Sent: Wednesday, September 22, 2004 4:39 PM
To: fdadockets@oc.fda.gov
Subject: BIO's Comments to Docket 2004N-0355 (Considerations for Developing Follow-On Protein Products) 

Please find attached the Biotechnology Industry Organization’s testimony for the Sept. 14-15, 2004 Public Meeting on Scientific Considerations Related to Developing Follow-On Protein Products (Docket 2004N-0355).    

 

Thank you, 

 

Jessica S. Oldham

Assistant, Science and Regulatory Affairs

Biotechnology Industry Organization

1225 Eye Street, N.W., Suite 400

Washington, D.C. 20005

Phone: (202) 962-9218

joldham@bio.org